EMvision Medical Devices Ltd
EMVision Medical Devices Limited is an Australian medical device company.
The business
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
Small Caps Research
No research on EMvision Medical Devices Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise EMV based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
EMVision Medical Devices Activates New US Site for Pivotal emu Brain Scanner Trial
Premier US stroke research hub UCLA Health will act as the site for a validation trial and continuous innovation study of EMVision Medical Devices’ (ASX: EMV) new emu brain scanner. The trial site will be led by principal investigator Dr May Nour, a dually-trained vascular and interventional neurologist and medical director of California’s first mobile […]
EMVision Medical Devices’ First Responder passes aeromedical testing for stroke and TBI care
EMVision Medical Devices (ASX: EMV) has completed aeromedical retrieval environment testing of its First Responder proof-of-concept (PoC) device to treat rural patients with stroke and traumatic brain injury (TBI). The company used the world-first brain imaging device to collect a series of volunteer scans in remote settings in collaboration with the Royal Flying Doctor Service […]
EMVision Medical Devices’ interim trial data shows promising results in identifying stroke types
Stage 2 interim data from a pre-validation trial by EMVision Medical Devices (ASX: EMV) has confirmed the positive performance of neurodiagnostic artificial intelligence (AI) algorithms in the diagnosis of suspected haemorrhagic or ischaemic strokes. The data showed the algorithms had an “encouraging ability” to identify patterns and features across complex ischaemic patient data sets, including […]
EMVision Medical Devices receives milestone payment for second-generation first responder brain scanner
EMVision Medical Devices (ASX: EMV) has received a $600,000 payment after achieving an “important milestone” for its second-generation first responder stroke detection device. The payment comes from the Australian Stroke Alliance, as part of the Commonwealth of Australia Medical Research Future Fund program. Under a project agreement with the Australian Stroke Alliance, EMVision will receive […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.